stemmacolore
Cerca

Challenging the role of chemotherapy in HER2 positive early breast cancer: PI3KCA pathways alteration and response to neoadjuvant pertuzumab-trastuzumab plus letrozole or paclitaxel in Hormone Receptor positive HER2 positive breast cancer patients.

Challenging the role of chemotherapy in HER2 positive early breast cancer: PI3KCA pathways alteration and response to neoadjuvant pertuzumab-trastuzumab plus letrozole or paclitaxel in Hormone Receptor positive HER2 positive breast cancer patients.

Tipologia

Ricerca di base/clinica

Stato

aperto

Copertura

Nazionale

Ruolo dell'Istituto

Partner

Ente finanziatore

Ministero della Salute

Anno di finanziamento

2016

Unità Operativa

UOC Oncologia 2

Principal Investigator

Prof.ssa Valentina Guarneri
Torna in alto